Work

High Expression of Class III β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer

Year: 2012

Type: article

Study design: Observational Study

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2012.11.003

Authors: Yihong Wang, Joseph A. Sparano, Susan Fineberg, Lesley Stead, Jaya Sunkara, Susan Band Horwitz, Hayley M. McDaid

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Breast Cancer Research Foundation, National Foundation for Cancer Research, National Cancer Research Institute, National Breast Cancer Foundation, National Research Foundation, National Institutes of Health, National Cancer Institute

Awards: Diverse Natural Products That Stabilize Microtubules, G1394397566, Paul Calabresi Career Development Award for Clinical Oncology (K12), G4549013559, G5503201567, G8545753832

OpenAlex ID: W2068720278

FWCI: 1.036

Cites: 30

Cited by: 33

Related to: 10